Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Cryogenic Solutions Inc. (CYGS) -- Ignore unavailable to you. Want to Upgrade?

To: antibash who wrote (3628)	5/6/1999 8:13:00 AM
From: Janice Shell	Respond to of 4028

Are you forgetting they're are a couple of more lawsuits approaching your door steps. Like the one AZNT's been threatening to bring since October? I've explained to you many times why the "AZNT Legal Team" wouldn't want to deal with our discovery questions, and why they'd be even less happy to see us on the witness stand. Why would anybody listen or believe one word you say? Because I do good research and am usually right. As I have been with AZNT. All along. I don't know why you have such difficulty seeing this: nothing you've ever been told--by Gary Dobry or by company officials--has actually happened.

To: antibash who wrote (3628)	5/6/1999 8:15:00 AM
From: Winthrop Troy	Read Replies (1) \| Respond to of 4028

Cryogenic Solutions Inc. Now Providing Beta Test Kits to Universities and Commercial Biotechs HOUSTON--(BUSINESS WIRE)--May 6, 1999--Cryogenic Solutions, Inc. (OTC BB: CYGS) has provided beta test kits of the company's proprietary single stranded DNA Intracellular Expression Vector (ssDNA IEV) to The Whittier Institute for Diabetes, University of California, San Diego; and to Brigham and Women's Hospital, an affiliate of Harvard Medical School. Requested Beta test kits await shipment to other investigators pending transfer agreements from the universities and research facilities. In addition to the University research centers listed here and in previous announcements, the company has shipped the vector to the Functional Genomics Division of Genzyme Corporation (NASDAQ:GENZ) and to AVI BioPharma, Inc (NASDAQ:AVII) with agreements to test the vector for various applications. A complete list of research facilities receiving beta test kits is maintained on the company website www.cygs.net. CONTACT: Cryogenic Solutions Inc., Houston Dell Gibson 713/780-1399 KEYWORD: TEXAS BW1053 MAY 06,1999 4:20 PACIFIC 07:20 EASTERN